Cyhoeddiad
2019
- Mattern, J., Roghi, C. S., Hurtz, M., Knauper, V., Edwards, D. R. and Poghosyan, Z. 2019. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells. Scientific Reports 9(1), article number: 12540. (10.1038/s41598-019-49021-3)
2012
- Hiscox, S. E. et al. 2012. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. BMC Cancer 12, article number: 458. (10.1186/1471-2407-12-458)
2009
- McLaren, J. E., Zuo, J., Grimstead, J. W., Poghosyan, Z., Bell, A. I., Rowe, M. and Brennan, P. 2009. STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells. Journal of General Virology 90(9), pp. 2239-2250. (10.1099/vir.0.011627-0)
- Maretzky, T. et al. 2009. Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer. Cancer Research 69(11), pp. 4573-4576. (10.1158/0008-5472.CAN-08-4766)
2008
- Zhong, J. L. et al. 2008. Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma. Molecular Cancer Research 6(3), pp. 383-394. (10.1158/1541-7786.MCR-07-2028)
2004
- Bounacer, A., McGregor, A., Skinner, J., Bond, J. A., Poghosyan, Z. and Wynford-Thomas, D. 2004. Mutant ras-induced proliferation of human thyroid epithelial cells requires three effector pathways. Oncogene 23(47), pp. 7839-7845. (10.1038/sj.onc.1208085)
Erthyglau
- Mattern, J., Roghi, C. S., Hurtz, M., Knauper, V., Edwards, D. R. and Poghosyan, Z. 2019. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells. Scientific Reports 9(1), article number: 12540. (10.1038/s41598-019-49021-3)
- Hiscox, S. E. et al. 2012. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. BMC Cancer 12, article number: 458. (10.1186/1471-2407-12-458)
- McLaren, J. E., Zuo, J., Grimstead, J. W., Poghosyan, Z., Bell, A. I., Rowe, M. and Brennan, P. 2009. STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells. Journal of General Virology 90(9), pp. 2239-2250. (10.1099/vir.0.011627-0)
- Maretzky, T. et al. 2009. Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer. Cancer Research 69(11), pp. 4573-4576. (10.1158/0008-5472.CAN-08-4766)
- Zhong, J. L. et al. 2008. Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma. Molecular Cancer Research 6(3), pp. 383-394. (10.1158/1541-7786.MCR-07-2028)
- Bounacer, A., McGregor, A., Skinner, J., Bond, J. A., Poghosyan, Z. and Wynford-Thomas, D. 2004. Mutant ras-induced proliferation of human thyroid epithelial cells requires three effector pathways. Oncogene 23(47), pp. 7839-7845. (10.1038/sj.onc.1208085)